| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
49,089 |
34,351 |
$2.56M |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,584 |
4,289 |
$279K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,697 |
3,685 |
$212K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,875 |
3,720 |
$187K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,719 |
7,055 |
$166K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,849 |
2,596 |
$151K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,174 |
2,163 |
$145K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,613 |
3,392 |
$119K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,656 |
2,414 |
$114K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,787 |
3,467 |
$102K |
| 92552 |
|
6,904 |
6,848 |
$98K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,452 |
1,422 |
$91K |
| Q3014 |
Telehealth originating site facility fee |
2,922 |
2,496 |
$56K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,410 |
3,049 |
$55K |
| 96156 |
|
510 |
479 |
$42K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,294 |
6,077 |
$41K |
| 92081 |
|
1,824 |
1,796 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,575 |
2,179 |
$30K |
| 90686 |
|
3,753 |
3,670 |
$29K |
| 90670 |
|
2,871 |
2,658 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,482 |
2,417 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,064 |
2,477 |
$16K |
| G9920 |
Screening performed and negative |
366 |
338 |
$14K |
| 90698 |
|
1,612 |
1,470 |
$13K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
880 |
870 |
$13K |
| 90633 |
|
1,685 |
1,604 |
$12K |
| 90651 |
|
1,432 |
1,425 |
$11K |
| 90680 |
|
1,373 |
1,244 |
$11K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
74 |
71 |
$11K |
| 99173 |
|
3,152 |
3,124 |
$10K |
| 86580 |
|
3,591 |
3,473 |
$10K |
| 90744 |
|
1,126 |
1,041 |
$9K |
| 90715 |
|
1,016 |
1,011 |
$7K |
| 85018 |
|
4,391 |
4,214 |
$7K |
| 90710 |
|
872 |
859 |
$7K |
| 83655 |
|
751 |
732 |
$6K |
| 99188 |
|
421 |
410 |
$6K |
| 87807 |
|
727 |
682 |
$6K |
| 90696 |
|
707 |
699 |
$5K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
116 |
116 |
$5K |
| 90734 |
|
711 |
708 |
$5K |
| 90697 |
|
559 |
515 |
$5K |
| 81002 |
|
2,527 |
2,493 |
$4K |
| 90700 |
|
456 |
444 |
$3K |
| 90716 |
|
431 |
421 |
$3K |
| 90707 |
|
355 |
348 |
$3K |
| 96127 |
|
444 |
422 |
$2K |
| 90688 |
|
238 |
238 |
$2K |
| 99000 |
|
1,379 |
1,105 |
$2K |
| 90655 |
|
241 |
237 |
$2K |
| 90619 |
|
244 |
244 |
$2K |
| 94760 |
|
15,706 |
12,658 |
$1K |
| 90647 |
|
168 |
159 |
$1K |
| 90621 |
|
169 |
169 |
$1K |
| 90648 |
|
120 |
119 |
$846.00 |
| 96151 |
|
32 |
32 |
$557.91 |
| 90677 |
|
76 |
60 |
$548.88 |
| 0072A |
|
15 |
15 |
$385.00 |
| 0001A |
|
14 |
14 |
$290.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
16 |
16 |
$210.08 |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
55 |
55 |
$171.63 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
18 |
16 |
$164.18 |
| 90620 |
|
17 |
17 |
$137.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
33 |
33 |
$128.29 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
19 |
19 |
$100.26 |
| 0002A |
|
12 |
12 |
$75.00 |
| 81000 |
|
33 |
30 |
$74.56 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
13 |
$40.86 |
| G9930 |
Patients who are receiving comfort care only |
26 |
26 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
15 |
12 |
$0.00 |